The US Food and Drug Administration (FDA) is recommending a twofold increase in the consumption of seafood among Americans as part of new dietary guidelines.
The US Food and Drug Administration (FDA) has given their sign of approval on Tuesday, Oct. 27, to Amgen's Imlygic (talimogene laherparepvec), a cancer immunotherapy against the dreaded melanoma lesions found in the skin and lymph nodes.
